MicroTransponder
↗Austin, Texas, USA
MicroTransponder is a commercial-stage medical device company that has developed the Vivistim® Paired VNS™ System, an innovative neurostimulation therapy designed to enhance rehabilitation for stroke survivors. The company's technology platform utilizes paired vagus nerve stimulation to induce neuroplasticity, helping the brain reorganize and regain motor function after neurological injury.
Founded by neuroscientists from the University of Texas at Dallas, the company focuses on 'Paired Plasticity'—the concept of timing nerve stimulation with specific tasks to strengthen neural circuits. Their flagship product, Vivistim, is the first and only FDA-approved drug-free stroke rehabilitation system of its kind, marking a significant shift in how chronic ischemic stroke is treated.
CLASSIFICATION
Company Type:MedTech
Therapeutic Areas:
Industry:Medical Devices
Sub-Industry:Neurostimulation / Neuromodulation
SIZE & FINANCIALS
Employees:51-200
Revenue:$10M-$50M
Founded:2007
Ownership:private
Status:operating
FUNDING
Stage:Series E
Total Raised:$145M
Investors:GPG Ventures, US Venture Partners (USVP), Action Potential Venture Capital (GSK), Osage University Partners, The Vertical Group
PIPELINE
Stage:Commercial
Lead Drug Stage:FDA Approved (Vivistim)
Modalities:Implantable Neurostimulation, Vagus Nerve Stimulation (VNS)
Active Trials:3
Trial Phases:Phase 2: 1 | Phase 3: 1 | Phase 4: 1
FDA Approvals:1
EMA Approvals:1
CORPORATE STRUCTURE
Key Partnerships:Brooks Rehabilitation, Shirley Ryan AbilityLab, University of Texas at Dallas (Research Partner)
COMPETITION
Position:Niche Player / Emerging Leader in Stroke Neuromodulation
Competitors:LivaNova, Medtronic, Abbott (Neuromodulation Division), SetPoint Medical, Cala Health
LEADERSHIP
Key Executives:
Richard Foust - CEO
Frank McEachern - Chairman
Scientific Founders:Dr. Michael Kilgard, Dr. Robert Rennaker
Board Members:Casey Tansey (USVP), Frank McEachern
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with MicroTransponder. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.